|
Référence |
Fournisseur |
Description |
Unité |
Prix HT |
|
|
|
EPY0002256 |
European Pharmacopoeia |
Fludarabine for peak identification |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002257 |
European Pharmacopoeia |
Pemetrexed disodium 2.5-hydrate CRS |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002258 |
European Pharmacopoeia |
N-Nitroso-diethylamine |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002259 |
European Pharmacopoeia |
N-nitroso-dimethylamine |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002260 |
European Pharmacopoeia |
N-nitroso-N-methyl-4-aminobutyric acid |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002261 |
European Pharmacopoeia |
N-Nitroso-dibutylamine |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002262 |
European Pharmacopoeia |
N-nitroso-ethyl-isopropylamine |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002263 |
European Pharmacopoeia |
N-nitroso-diisopropylamine |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002264 |
European Pharmacopoeia |
N-Nitroso-dipropylamine |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002265 |
European Pharmacopoeia |
Procaine benzylpenicillin for peak identification A |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002266 |
European Pharmacopoeia |
Zidovudine for system suitability A CRS |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002267 |
European Pharmacopoeia |
Ethanolamine CRS |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002268 |
European Pharmacopoeia |
beta-sitosterol for peak identification |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002269 |
European Pharmacopoeia |
Trazodone hydrochloride CRS |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002270 |
European Pharmacopoeia |
Trazodone for system suitability CRS |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002271 |
European Pharmacopoeia |
Flurbiprofen for peak identification CRS |
|
164.56 CHF
172.79 €
|
|
|
|
EPY0002272 |
European Pharmacopoeia |
Bisacodyl for system suitability A |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002273 |
European Pharmacopoeia |
Fluticasone furoate For Peak Identification |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002274 |
European Pharmacopoeia |
Fluticasone furoate CRS |
|
164.56 CHF
172.79 €
|
|
|
|
EPY0002275 |
European Pharmacopoeia |
Oxybutynin hydrochloride for system suitability CRS |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002276 |
European Pharmacopoeia |
Dipotassium clorazepate monohydrate-*psy |
|
164.56 CHF
172.79 €
|
|
|
|
EPY0002278 |
European Pharmacopoeia |
Methylaminolevulinate impurity B |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002280 |
European Pharmacopoeia |
Somatostatin Impurity B |
|
175.44 CHF
184.21 €
|
|
|
|
EPY0002281 |
European Pharmacopoeia |
Somatostatin impurity F CRS |
|
175.44 CHF
184.21 €
|
|
|
|
EPY0002282 |
European Pharmacopoeia |
Phenoxybenzamine hydrochloride CRS |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002283 |
European Pharmacopoeia |
Phenoxybenzamine impurity B SCR |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002284 |
European Pharmacopoeia |
Phenoxybenzamine for system suitability SCR |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002285 |
European Pharmacopoeia |
Croscarmellose sodium CRS |
|
164.56 CHF
172.79 €
|
|
|
|
EPY0002286 |
European Pharmacopoeia |
Terazosin for system suitability A |
|
157.76 CHF
165.65 €
|
|
|
|
EPY0002287 |
European Pharmacopoeia |
4-Dodecylresorcinol CRS |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002288 |
European Pharmacopoeia |
Chelerythrine chloride CRS |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002289 |
European Pharmacopoeia |
Dipotassium clorazepate monohydrate - reference spectrum |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002290 |
European Pharmacopoeia |
Chenodeoxycholic acid for system suitability |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002291 |
European Pharmacopoeia |
Chenodeoxycholic acid for peak identification |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002292 |
European Pharmacopoeia |
Ciclosporin for system suitability A |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002293 |
European Pharmacopoeia |
Fluticasone furoate for system suitability CRS |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002294 |
European Pharmacopoeia |
Pravastatin 1,1,3,3-tetramethylbutylamine for assay |
|
164.56 CHF
172.79 €
|
|
|
|
EPY0002295 |
European Pharmacopoeia |
Nitrofural for peak identification A |
|
170.00 CHF
178.50 €
|
|
|
|
EPY0002296 |
European Pharmacopoeia |
Alfacalcidol impurity B |
|
1,047.20 CHF
1,099.56 €
|
|
|
|
EPY0002297 |
European Pharmacopoeia |
Terpin impurity D |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002298 |
European Pharmacopoeia |
Formoterol for system suitability |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002299 |
European Pharmacopoeia |
Nebivolol hydrochloride CRS |
|
1,047.20 CHF
1,099.56 €
|
|
|
|
EPY0002306 |
European Pharmacopoeia |
Nebivolol for peak identification |
|
1,047.20 CHF
1,099.56 €
|
|
|
|
EPY0002307 |
European Pharmacopoeia |
Palladium solution |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002311 |
European Pharmacopoeia |
Trypsin for aprotinin assay BRP |
|
152.32 CHF
159.94 €
|
|
|
|
EPY0002315 |
European Pharmacopoeia |
Atorvastatin calcium CRS |
|
152.32 CHF
159.94 €
|
|
|
|
EPZ1900000 |
European Pharmacopoeia |
Zidovudine (60mg) 60mg |
|
152.32 CHF
159.94 €
|
|
|
|
EPZ1904000 |
European Pharmacopoeia |
Zidovudine impurity B 1-(3-chloro-2,3-dideoxy-ß-D-ribofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione 5mg |
|
152.32 CHF
159.94 €
|
|
|
|
EPZ2000000 |
European Pharmacopoeia |
Zinc acexamate TBC |
|
152.32 CHF
159.94 €
|
|
|
|
EPZ2000010 |
European Pharmacopoeia |
Zinc acexamate impurity A 6-[[6-(acetylamino)hexanoyl]amino] hexanoic acid TBC |
|
152.32 CHF
159.94 €
|
|
